Registry Study on the Effectiveness of Rivaroxaban in Patients With Non-valvular Atrial Fibrillation Managed by General Practitioners(GENERAL Study).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Atrial fibrillation; Embolism
- Focus Therapeutic Use
- Acronyms GENeRAL
- 29 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Oct 2015 New trial record